TABLE 2.
ACMG classifications of three pathogenic variants in AD.
| Gene | Variant types | Transmembrane | ACMG classifications | No. |
| APP | Missense | + | Pathogenic | 11 |
| APP | Missense | + | Likely pathogenic | 6 |
| APP | Missense | + | VUS | 2 |
| APP | Missense | + | Benign | 2 |
| APP | NA | NA | VUS | 2 |
| APP | Missense | − | Pathogenic | 5 |
| APP | Missense | − | Likely pathogenic | 7 |
| APP | Missense | − | VUS | 27 |
| APP | Missense | − | Benign | 1 |
| APP | Indel | − | Likely pathogenic | 1 |
| APP | Indel | NA | VUS | 2 |
| PSEN1 | Missense | + | Pathogenic | 85 |
| PSEN1 | Missense | + | Likely pathogenic | 95 |
| PSEN1 | Missense | + | VUS | 7 |
| PSEN1 | Missense | − | Pathogenic | 37 |
| PSEN1 | Missense | − | Likely pathogenic | 46 |
| PSEN1 | Missense | − | VUS | 25 |
| PSEN1 | Indel | + | Pathogenic | 6 |
| PSEN1 | Indel | + | Likely pathogenic | 5 |
| PSEN1 | Indel | − | Pathogenic | 3 |
| PSEN1 | Indel | − | Likely pathogenic | 2 |
| PSEN1 | Indel | − | VUS | 3 |
| PSEN1 | Frameshift | − | Pathogenic | 1 |
| PSEN1 | Missense,CNV | NA | Pathogenic | 6 |
| PSEN1 | splicing | NA | Likely pathogenic | 2 |
| PSEN2 | Missense | + | Pathogenic | 3 |
| PSEN2 | Missense | + | Likely pathogenic | 3 |
| PSEN2 | Missense | + | VUS | 22 |
| PSEN2 | Missense | + | Likely benign | 1 |
| PSEN2 | Missense | + | Benign | 2 |
| PSEN2 | Missense | − | Likely pathogenic | 1 |
| PSEN2 | Missense | − | VUS | 21 |
| PSEN2 | Missense | − | Benign | 3 |
| PSEN2 | Splicing | NA | Likely pathogenic | 1 |
| PSEN2 | Frameshift | NA | Pathogenic | 2 |
| PSEN2 | Frameshift | − | Pathogenic | 2 |
| PSEN2 | Frameshift | − | Likely pathogenic | 1 |
| PSEN2 | Frameshift | − | VUS | 1 |
No., number; CNV, copy number variation; VUS, uncertain significance; NA, not applied.